drugset / Trial / NCT05722951

Metformin Efficacy and Safety in Epileptic Patients

NCT05722951

Phase 3 Completed 60 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to Evaluating Metformin Efficacy and Safety when Co-administered with Antiepileptic Drugs in Patients with Seizures. The main question it aims to answer is: * Does metformin have beneficial effect on epileptic patients? * How metformin can affect epileptic patient's health? Participants will be divided into 2 groups (control group and treatment group) * Control group will receive standard treatment (levetiracetam \&/or sodium valproate). * Treatment group will receive standard treatment (levetiracetam \&/or sodium valproate) + metformin

Timeline

Start
2022-10-18
Primary completion
2024-06-20
Completion
2024-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule
Background Levetiracetam Other / unclassified
Background Valproate Small molecule

Indications